经尿道等离子电切术治疗伴轻度血小板减少良性前列腺增生的临床研究

汪小勇, 宋周良, 丁天生, 等. 经尿道等离子电切术治疗伴轻度血小板减少良性前列腺增生的临床研究[J]. 临床泌尿外科杂志, 2020, 35(3): 214-216. doi: 10.13201/j.issn.1001-1420.2020.03.011
引用本文: 汪小勇, 宋周良, 丁天生, 等. 经尿道等离子电切术治疗伴轻度血小板减少良性前列腺增生的临床研究[J]. 临床泌尿外科杂志, 2020, 35(3): 214-216. doi: 10.13201/j.issn.1001-1420.2020.03.011
WANG Xiaoyong, SONG Zhouliang, DING Tiansheng, et al. Clinical investigation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia with blood platelet mild decreasing[J]. J Clin Urol, 2020, 35(3): 214-216. doi: 10.13201/j.issn.1001-1420.2020.03.011
Citation: WANG Xiaoyong, SONG Zhouliang, DING Tiansheng, et al. Clinical investigation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia with blood platelet mild decreasing[J]. J Clin Urol, 2020, 35(3): 214-216. doi: 10.13201/j.issn.1001-1420.2020.03.011

经尿道等离子电切术治疗伴轻度血小板减少良性前列腺增生的临床研究

详细信息
    通讯作者: 汪小勇,E-mail:wangxiaoyong123@163.com
  • 中图分类号: R697

Clinical investigation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia with blood platelet mild decreasing

More Information
  • 目的:研究经尿道等离子电切术(PKRP)治疗伴有轻度血小板(PLT)减少的良性前列腺增生(BPH)临床安全及可行性。方法:回顾性分析PKRP治疗BPH伴PLT轻度减少54例(PLT减少组),年龄53~85岁,前列腺体积24~125 mL。PLT计数51~89×109/L,平均(73.4±10.9)×109/L,3例(PLT<52×109/L)给予提升PLT治疗。将同期入院PLT正常前列腺增生患者54例作为对照组,年龄59~87岁,前列腺体积24~163 mL。两组患者术前凝血无异常。比较两组术中及术后出血、手术时间、手术前后血红蛋白减少量、膀胱冲洗时间、拔管时间及排尿困难解除情况。结果:两组手术均顺利完成。PLT减少组患者手术时间41~266 min,平均(106.9±38.0) min;手术前后血红蛋白减少4~40 g/L,平均(9.9±6.0) g/L;膀胱冲洗15~70 h,平均(31.2±12.7) h;拔管时间3.5~7 d,平均(5.0±0.7) d;术后2例输血,3例短期尿潴留,治疗后好转。对照组患者手术时间40~210 min,平均(103.9±36.1) min;手术前后血红蛋白减少3~32 g/L,平均(10.8±6.6) g/L;膀胱冲洗16~162 h,平均(36.3±22.6) h;拔管时间3.5~9.0 d,平均(5.1±1.0) d;术后3例出血,其中1例手术止血,均无输血;4例尿潴留,2例治疗后好转。两组术中术后出血、手术时间、手术前后血红蛋白减少量、膀胱冲洗时间、尿管拔除时间及排尿困难解除比较差异无统计学意义(P>0.05)。结论:对伴有轻度PLT减少的BPH患者,PKRP是安全可行的。
  • 加载中
  • [1]

    叶林,沈燕丽,侯旭,等.前列腺增生经尿道电切术后出血的原因与处理(附55例报告)[J].临床泌尿外科杂志,2005,20(1):27-29.

    [2]

    Wendt-Nordahl G,Bucher B,Häcker A,et al.Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center[J].J Endourol,2007,21(9):1081-1087.

    [3]

    Jens R,Dogu T,Rainer K,et al.Complications of Transurethral Resection of the Prostate(TURP)-Incidence,Management,and Prevention[J].Eur Urol,2006,50(5):969-980.

    [4]

    Lynch M,Sriprasad S,Subramonian K,et al.Postoperative hemorrhage following transurethral resection of the prostate(TURP)and photoselective vaporisation of the prostate(PVP)[J].Ann R Coll Surg Engl,2010,92(7):555-558.

    [5]

    Foley SJ,Bailey DM.Microvessel density in prostatic hyperplasia[J].BJU Int,2000,85(1):70-73.

    [6]

    Enver MK,Hoh I,Chinegwundoh FI.The management of aspirin in transurethral prostatectomy:current practice in the UK[J].Ann R Coll Surg Engl,2006,88(3):280-283.

    [7]

    Yee CH,Wong JH,Chiu PK,et al.Secondary hemorrhage after bipolar transurethral resection and vaporization of prostate[J].Urol Ann,2016,8(4):458-463.

    [8]

    Fagerström T,Nyman CR,Hahn RG.Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique:a single-centre randomized trial of 202 patients[J].BJU Int,2010,105(11):1560-1564.

    [9]

    Hu Y,Dong X,Wang G,et al.Five-Year Follow-Up Study of Transurethral Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia[J].J Endourol,2015,30(1):97-101.

    [10]

    Dundee PE,Bouchier-Hayes DM,Costello AJ.An option for prostatectomy in the thrombocytopenic patient:a continued role for the Nd:YAG laser[J].Photomed Laser Surg,2005,23(3):333-334.

    [11]

    Rose K,Lambros S,Brian M.Robot-assisted laparoscopic prostatectomy performed in a patient with severe thrombocytopenia due to primary myelofibrosis[J].Can Urol Assoc J,2009,3(4):E23-E24.

  • 加载中
计量
  • 文章访问数:  472
  • PDF下载数:  819
  • 施引文献:  0
出版历程
收稿日期:  2018-10-15

目录